Skip to main content
Fig. 11 | Cancer Cell International

Fig. 11

From: Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells

Fig. 11

ADCC experiments on the MDA-MB231 breast cancer and the HT-29 colon cancer cell lines using the ImageXpress® Pico real time cell imaging system. a The ADCC response against MDA-MB231 cells by MNCs using antibody 3B4. A significant decrease in the number target cells was detected at 72 h compared to the Isotype control p = 0.0172. b The ADCC response against HT-29 cell by MNCs using antibody 10E8. A decrease in the number target cells about 50% was detected at 48 h p = 0.0216

Back to article page